Searched for
SINGLE DOSE VACCINE
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- HPV vaccination drive reaches 50 lakh girls in three monthsIndia's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...
- World's most contagious disease detected in California wastewater: Key signs of virus and symptoms you should watchMeasles outbreak: California health officials are alarmed by the detection of measles in wastewater, coinciding with the state's worst outb...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- Bengal CM Suvendu Adhikari launches cervical cancer vaccination drive for over 7.5 lakh girls aged 14 yearsWest Bengal Chief Minister Suvendu Adhikari has initiated a statewide Human Papillomavirus vaccination campaign. This program targets appro...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Forget Hantavirus and Ebola, this deadly virus has killed over 500, mostly children, in India's neighbouring country. Check signs and symptomsA severe measles outbreak in Bangladesh has claimed over 500 lives, predominantly young children, with over 60,000 suspected cases reported...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Dr Reddy’s gets drug regulator's nod for Phase III bridging trials of Sputnik Light covid vaccineAfter launching Sputnik V, Russia introduced a new single-dose vaccine, called Sputnik Light, in May. As in the case of Sputnik, Sputnik Li...
- Johnson & Johnson says booster dose increased antibodies in early-stage studiesA second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people rec...
- From game-changer to back-up: J&J's COVID vaccine struggles in EuropeThe Johnson & Johnson single-dose vaccine was considered to be a game changer when it rolled out. However, two months post it's arrival, it...
- New study says single dose of Covishield sufficient for Covid infected peopleThe study was designed to assess the immunological memory response in patients.
- India will examine claim of single-dose version of Sputnik V vaccine: NITI Aayog member V K Paul"In case of Sputnik Light, they (developers) are saying that the first dose is enough. We are examining this claim. We will go through its ...
- Fear grips India's vast informal workforce as vaccine supply runs lowUntil April-end, only 9% of India's population received a single dose, and with the vaccination campaign open for all, many states are runn...
- Single dose of Pfizer and Astrazeneca Covid vaccines highly effective: StudiesIsraeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on mo...
- Johnson & Johnson’s one-dose vaccine elicits ‘strong immune response’Neutralising antibodies formed in more than 90% of the participants by day 29 and in 100% of the participants aged 18-55 years on day 57.
- Single Covid-19 vaccine dose or double? Data put regulators in a fixThe US Food and Drug Administration has released its findings on the Pfizer/BioNtech efficacy data where it suggested that the vaccine at a...
Load More
